From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease: Out with the Old, in with the New

J Clin Med. 2024 Feb 2;13(3):880. doi: 10.3390/jcm13030880.

Authors

Iyiad Alabdul Razzak¹, Mazen Noureddin², Hirsh D Trivedi^{3

4}

Affiliations

¹ Department of Medicine, St. Elizabeth's Medical Center, Tufts School of Medicine, Boston, MA 02111, USA.
² Houston Research Institute and Houston Methodist Hospital, Houston, TX 77030, USA.
³ Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
⁴ Karsh Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease (CLD) affecting a quarter of the global population [...].

Publication types

Editorial